The Role of UNIFI Scientific Information System in Assisting with Electronic Records Regulation Compliance

Significance of the Topic

Electronic records and data integrity are critical elements in regulated pharmaceutical and biotechnology environments. Compliance with global requirements such as 21 CFR Part 11 (FDA) and Annex 11 (EU) ensures reliable and traceable laboratory operations. Robust informatics platforms help laboratories transition from paper to electronic records, reducing risks associated with data manipulation and incomplete documentation.

Objectives and Overview

This white paper examines the Waters™ UNIFI™ Scientific Information System:

• Assessing its readiness for 21 CFR Part 11 and related Data Integrity guidelines
• Describing core technical controls to support regulatory compliance
• Illustrating strategies for global implementation in regulated laboratories

Methodology and Instrumentation

UNIFI combines a scalable Oracle relational database with a client-server architecture. Key technical controls include:

• Buffering of data acquisition during network outages
• Automated backup and disaster recovery scripts
• Secure archiving and retrieval of raw and processed data
• Granular role-based access control and device management
• Comprehensive audit trails and event logging
• Electronic signature workflows with two-factor authentication

Main Results and Discussion

Implementation of UNIFI demonstrates:

• Seamless integration with chromatography and mass spectrometry instruments
• Unalterable linking of electronic signatures to data records
• Automated audit trail capture of all data, metadata, and system events
• Flexible signature methods with configurable review levels
• Efficient report search and retrieval features

Benefits and Practical Applications

By centralizing scientific data, UNIFI offers:

• Improved Data Integrity and compliance confidence
• Streamlined audit preparation and faster responses to regulators
• Reduced risk of data loss through secure backups and archiving
• Clear traceability between raw data, processing methods, and final reports

Future Trends and Opportunities

The continued evolution of electronic records management includes:

• Integration with laboratory information management systems and electronic lab notebooks
• Expansion of cloud-based data storage and collaborative workflows
• Enhanced analytics and AI-driven data review
• Harmonization of global data integrity regulations

Conclusion

Waters UNIFI provides a comprehensive suite of technical controls designed to support electronic record and signature regulations. Its robust architecture and rich compliance features facilitate transition to a fully electronic environment while ensuring data integrity and traceability.

Instrumentation

UNIFI supports data from a wide range of analytical systems including:

• HPLC, UPLC, GC, UV detectors
• Mass spectrometry (MS, GC-MS) and NMR
• Analog devices via eSAT/IN interfaces
• Laboratory network devices and client workstations

Reference

1. FDA Code of Federal Regulations Title 21 Part 11, 1997
2. FDA Guidance: Current Good Manufacturing Practices – Records and Reports, 2010
3. FDA Draft Guidance: Data Integrity and Compliance with CGMP, 2016
4. OECD GLP Principles and Compliance Monitoring, Guidance 17, 2017
5. FDA Electronic Records and Signatures Policy Guide, 1999
6. WHO Guidance on Good Data and Record Management Practices, 2016